NCT02290041View on ClinicalTrials.gov

Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2019

Conditions
Discordant Immunological Response in HIV Infected Subjects
Interventions
DRUG

Infusion of MSC

Intravenous infusion of 4 doses of adipose tissue derived allogeneic adult mesenchymal stem cells (1 million MSCs/Kg, weeks 0-4-8-20).

DRUG

Infusion of placebo

Infusion of placebo (weeks 0-4-8-20)

Trial Locations (1)

41013

Virgen del Rocío University Hospital, Seville

All Listed Sponsors
collaborator

Iniciativa Andaluza en Terapias Avanzadas

OTHER

lead

Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

OTHER

NCT02290041 - Treatment With MSC in HIV-infected Patients With Controlled Viremia and Immunological Discordant Response | Biotech Hunter | Biotech Hunter